Boule Diagnostics Balance Sheet Health
Financial Health criteria checks 4/6
Boule Diagnostics has a total shareholder equity of SEK467.3M and total debt of SEK149.5M, which brings its debt-to-equity ratio to 32%. Its total assets and total liabilities are SEK764.0M and SEK296.7M respectively. Boule Diagnostics's EBIT is SEK38.3M making its interest coverage ratio 6.1. It has cash and short-term investments of SEK62.6M.
Key information
32.0%
Debt to equity ratio
kr149.50m
Debt
| Interest coverage ratio | 6.1x |
| Cash | kr62.60m |
| Equity | kr467.30m |
| Total liabilities | kr296.70m |
| Total assets | kr764.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BDAB.F's short term assets (SEK333.5M) exceed its short term liabilities (SEK207.7M).
Long Term Liabilities: BDAB.F's short term assets (SEK333.5M) exceed its long term liabilities (SEK89.0M).
Debt to Equity History and Analysis
Debt Level: BDAB.F's net debt to equity ratio (18.6%) is considered satisfactory.
Reducing Debt: BDAB.F's debt to equity ratio has increased from 19.8% to 32% over the past 5 years.
Debt Coverage: BDAB.F's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: BDAB.F's interest payments on its debt are well covered by EBIT (6.1x coverage).